Harnessing RNA-Protein Interactions for Therapeutic Interventions.

Area of Science:

• Biochemistry
• Molecular Biology
• Drug Discovery

Background:

• RNA-protein interactions are vital in numerous diseases, including cancer and viral infections.
• Targeting these interactions offers a therapeutic avenue, but challenges remain in achieving specificity and affinity.
• Limited molecular understanding has historically hindered the development of effective inhibitors.

Purpose of the Study:

• To review key small molecule and peptide-based inhibitors developed over the last decade.
• To analyze their effectiveness in disrupting pathogenic RNA-protein interactions (RBPs).
• To discuss challenges and future directions in developing targeted therapeutics.

Main Methods:

• Structural and biochemical characterization of RNA-protein interactions.
• High-throughput screening technologies for inhibitor identification.
• Computational modeling for optimizing potential drug candidates.

Main Results:

• Identification of promising small molecule and peptide inhibitors targeting RBPs.
• Demonstrated disruption of critical RNA-protein interactions in various organisms (eukaryotes, prokaryotes, viruses).
• Progress in understanding molecular mechanisms and optimizing inhibitor properties.

Conclusions:

• Significant advancements have been made in developing inhibitors for pathogenic RNA-protein interactions.
• Future efforts must focus on enhancing inhibitor specificity and minimizing off-target effects.
• This field holds great promise for novel therapeutic agent development.